PUBLISHER: The Business Research Company | PRODUCT CODE: 2161001
PUBLISHER: The Business Research Company | PRODUCT CODE: 2161001
Implantable medical device batteries are specialized energy storage systems engineered to safely and reliably supply power to implanted medical devices. They are designed to provide high energy density, predictable discharge characteristics, long-term stability, hermetic protection, and stringent safety performance to ensure dependable device operation throughout extended implantation periods.
The primary battery chemistries of implantable medical device batteries include lithium iodine batteries, lithium ion batteries, lithium silver vanadium oxide batteries, lithium carbon monofluoride batteries, and other battery chemistries. Lithium iodine batteries refer to primary batteries that use lithium as the anode and iodine-based materials as the cathode system, delivering stable and reliable power for certain implantable medical devices. These batteries are available as primary batteries and rechargeable batteries and are packaged in hermetically sealed batteries, polymer encapsulated batteries, and other packaging configurations. Their applications include cardiac rhythm management devices, neurostimulation devices, cochlear implants, implantable drug delivery systems, implantable monitoring devices, and other implantable medical devices, and they are used by end users such as medical device manufacturers or original equipment manufacturers, battery manufacturers or specialized battery suppliers, contract manufacturers, and research and development organizations.
Tariffs are influencing the implantable medical device batteries market by increasing the cost of imported lithium materials, specialty battery components, electronic components, and manufacturing equipment required for implantable battery production. This is raising manufacturing expenses and may increase procurement costs for medical device manufacturers, particularly in North America, Europe, and Asia-Pacific regions that rely on international medical battery and component supply chains. Battery-intensive segments such as lithium iodine, lithium-ion, lithium silver vanadium oxide, and lithium carbon monofluoride batteries are most affected because of their dependence on specialized materials and components. However, tariffs are also encouraging domestic battery manufacturing, regional supplier diversification, and investment in localized medical device battery production, strengthening long-term supply chain resilience.
The implantable medical device batteries market research report is one of a series of new reports from The Business Research Company that provides implantable medical device batteries market statistics, including implantable medical device batteries industry global market size, regional shares, competitors with a implantable medical device batteries market share, detailed implantable medical device batteries market segments, market trends and opportunities, and any further data you may need to thrive in the implantable medical device batteries industry. This implantable medical device batteries market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable medical device batteries market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to increasing adoption of implantable medical devices, rising demand for long-lasting power sources for medical devices, growing utilization of cardiac rhythm management devices, increasing demand for dependable battery performance, and rising emphasis on implantable device safety.
The implantable medical device batteries market size is expected to see strong growth in the next few years. It will grow to $1.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. Growth during the forecast period is likely to be driven by increasing adoption of advanced neurostimulation devices, rising demand for smaller implantable medical devices, growing development of rechargeable implantable batteries, increasing demand for higher energy density, and greater adoption of next-generation implantable drug delivery systems. Key trends during the forecast period include increasing development of high-energy-density implantable batteries, greater adoption of long-life primary battery technologies, rising development of miniaturized implantable power sources, increasing focus on hermetically sealed battery designs, and growing demand for predictable and stable battery discharge.
The increasing prevalence of cardiovascular and neurological disorders is expected to drive the growth of the implantable medical device batteries market going forward. Cardiovascular and neurological disorders refer to chronic conditions affecting the heart, blood vessels, brain, spinal cord, and nervous system, which often require long-term treatment using implantable medical devices such as pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and neurostimulators. The rising prevalence of cardiovascular and neurological disorders is associated with an aging global population, which increases the likelihood of chronic cardiovascular and neurological conditions among older adults. Implantable medical device batteries support the management of cardiovascular and neurological disorders by supplying reliable and long-lasting power to implanted devices. They enable the continuous functioning of devices such as pacemakers, implantable cardioverter defibrillators, and neurostimulators, contributing to treatment effectiveness and improved patient outcomes. For instance, in August 2025, according to the National Institutes of Health (NIH), a US-based federal government agency, cardiovascular prevalence is projected to increase by 90.0% from 2025 to 2050, with cardiovascular deaths rising from 20.5 million in 2025 to 35.6 million in 2050. Therefore, the increasing prevalence of cardiovascular and neurological disorders is driving the growth of the implantable medical device batteries market.
Major companies operating in the implantable medical device batteries market are focusing on developing advanced medical battery solutions, such as high-pulse medical-grade batteries, to improve power reliability, operating life, and performance in critical medical devices. High-pulse medical-grade batteries are specialized batteries engineered to provide stable, high-rate power pulses while maintaining dependable performance under demanding environmental conditions and meeting the power requirements of medical devices. For instance, in April 2026, EVE Energy Co. Ltd., a China-based battery manufacturer, unveiled the CR123AP medical-grade battery at the China International Medical Equipment Fair (CMEF) Spring Edition. Developed as an advanced medical battery solution, the CR123AP incorporates high-pulse output technology, extended cycle life, strong rate capability, and improved low-temperature performance, delivering pulse output capability up to 5.92 times that of competing products at -20°C. The battery also employs a dry electrode manufacturing process to lower carbon emissions while enhancing electrode conductivity and mechanical stability, enabling dependable power delivery across critical medical equipment and contributing to the wider medical battery ecosystem serving implantable devices.
In January 2026, Ilika plc, a UK-based solid-state battery technology company, partnered with Cirtec Medical LLC to manufacture batteries for active implantable medical devices. Through this partnership, the companies aim to accelerate the commercialization and integration of Ilika's Stereax miniature solid-state batteries into next-generation implantable medical devices by combining Ilika's expertise in battery technology with Cirtec Medical's medical device design, engineering, and manufacturing capabilities. Cirtec Medical LLC is a US-based medical device development and manufacturing company that provides implantable medical device solutions, including manufacturing support for miniature solid-state batteries used in implantable applications.
Major companies operating in the implantable medical device batteries market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Inspire Medical Systems Inc., Cochlear Limited, Mainstay Medical Holdings plc, EnerSys, Resonetics LLC, EVE Energy Co. Ltd., Maxell Ltd., Wyon AG, Ilika plc, Ensurge Micropower ASA, Cymbet Corporation, Excellatron Solid State LLC, InjectPower S.r.l., Integer Holdings Corporation
North America was the dominating region in the implantable medical device batteries market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the implantable medical device batteries market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable medical device batteries market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The implantable medical device batteries consists of sales of implantable lithium-ion batteries, lithium-iodine batteries, lithium silver vanadium oxide batteries, lithium carbon monofluoride batteries, rechargeable implantable batteries, and primary implantable batteries. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Medical Device Batteries Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses implantable medical device batteries market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable medical device batteries? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable medical device batteries market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope are limited to 20% of content and consultant support time is limited to 8 hours.